title: [QT prolongation and second-generation antipsychotics: overdose and therapeutic dosage].
authors.forename: Benoît
authors.initials: B
authors.lastname: Trojak
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Pinoit
authors.forename: Anne
authors.initials: A
authors.lastname: Disson-Dautriche
authors.forename: Bernard
authors.initials: B
authors.lastname: Bonin
authors.forename: André
authors.initials: A
authors.lastname: Giusselmann
mesh_terms: D000328:Adult; D000077582:Amisulpride; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000506:poisoning; D001569:Benzodiazepines / Q000506:poisoning; D062787:Drug Overdose; D004562:Electrocardiography / Q000187:drug effects; D005260:Female; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced*; D000077152:Olanzapine; D013469:Sulpiride / Q000031:analogs & derivatives* / Q000506:poisoning; D016171:Torsades de Pointes / Q000139:chemically induced
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D013469:Sulpiride; D000077582:Amisulpride; D000077152:Olanzapine